{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:26:59Z","timestamp":1793039219684,"version":"4.5.0"},"reference-count":49,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by pathologic immune activation in which prompt recognition and initiation of immune suppression is essential for survival. Children with HLH have many overlapping clinical features with critically ill children with sepsis and systemic inflammatory response syndrome (SIRS) in whom alternative therapies are indicated. To determine whether plasma biomarkers could differentiate HLH from other inflammatory conditions and to better define a core inflammatory signature of HLH, concentrations of inflammatory plasma proteins were compared in 40 patients with HLH to 47 pediatric patients with severe sepsis or SIRS. Fifteen of 135 analytes were significantly different in HLH plasma compared with SIRS\/sepsis, including increased interferon-\u03b3 (IFN-\u03b3)\u2013regulated chemokines CXCL9, CXCL10, and CXCL11. Furthermore, a 2-analyte plasma protein classifier including CXCL9 and interleukin-6 was able to differentiate HLH from SIRS\/sepsis. Gene expression in CD8+ T cells and activated monocytes from blood were also enriched for IFN-\u03b3 pathway signatures in peripheral blood cells from patients with HLH compared with SIRS\/sepsis. This study identifies differential expression of inflammatory proteins as a diagnostic strategy to identify critically ill children with HLH, and comprehensive unbiased analysis of inflammatory plasma proteins and global gene expression demonstrates that IFN-\u03b3 signaling is uniquely elevated in HLH. In addition to demonstrating the ability of diagnostic criteria for HLH and sepsis or SIRS to identify groups with distinct inflammatory patterns, results from this study support the potential for prospective evaluation of inflammatory biomarkers to aid in diagnosis of and optimizing therapeutic strategies for children with distinctive hyperinflammatory syndromes.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004287","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T22:58:15Z","timestamp":1630364295000},"page":"3457-3467","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":70,"title":["IFN-\u03b3 signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0847-904X","authenticated-orcid":false,"given":"Howard","family":"Lin","sequence":"first","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks P.","family":"Scull","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch R.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA;"},{"name":"Section of Rheumatology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal A.","family":"Abhyankar","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olive E.","family":"Eckstein","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Zinn","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lubega","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Agrusa","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"El Mallawaney","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9243-9544","authenticated-orcid":false,"given":"Nitya","family":"Gulati","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-1934","authenticated-orcid":false,"given":"Lisa","family":"Forbes","sequence":"additional","affiliation":[{"name":"Section of Allergy and Immunology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5684-5457","authenticated-orcid":false,"given":"Ivan","family":"Chinn","sequence":"additional","affiliation":[{"name":"Section of Allergy and Immunology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikhia","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Velasquez","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana","family":"Goldman","sequence":"additional","affiliation":[{"name":"Section of Critical Care Medicine, Department of Pediatrics, Texas Children\u2019s Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Bashir","sequence":"additional","affiliation":[{"name":"Section of Critical Care Medicine, Department of Pediatrics, Texas Children\u2019s Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong","family":"Lam","sequence":"additional","affiliation":[{"name":"Section of Critical Care Medicine, Department of Pediatrics, Texas Children\u2019s Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Muscal","sequence":"additional","affiliation":[{"name":"Section of Rheumatology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-0706","authenticated-orcid":false,"given":"Michael. M.","family":"Henry","sequence":"additional","affiliation":[{"name":"Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay N.","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Division of Hematology, Children's National Medical Center, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ladisch","sequence":"additional","affiliation":[{"name":"Division of Hematology, Children's National Medical Center, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Hermiston","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, University of California, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren K.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, University of California, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jeng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Hematology\/Oncology, Lucile Packard Children's Hospital, Stanford University, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-5856","authenticated-orcid":false,"given":"Ahmed","family":"Naqvi","sequence":"additional","affiliation":[{"name":"Division of Haematology\/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-6263","authenticated-orcid":false,"given":"Kenneth","family":"McClain","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Section of Critical Care Medicine, Department of Pediatrics, Texas Children\u2019s Hospital, Houston, TX;"},{"name":"Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz-Kwong","family":"Man","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Jordan","sequence":"additional","affiliation":[{"name":"Divisions of Immunobiology and Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Allen","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"issue":"2","key":"2021091015301196300_B1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer."},{"issue":"15","key":"2021091015301196300_B2","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood."},{"key":"2021091015301196300_B3","doi-asserted-by":"crossref","first-page":"e27929","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO)","author":"Jordan","year":"2019","journal-title":"Pediatr Blood Cancer."},{"issue":"1","key":"2021091015301196300_B4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med."},{"issue":"4","key":"2021091015301196300_B5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med."},{"issue":"10","key":"2021091015301196300_B6","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2001.19.10.2665","article-title":"Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"19","author":"Imashuku","year":"2001","journal-title":"J Clin Oncol."},{"issue":"3","key":"2021091015301196300_B7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00443367","article-title":"Familial hemophagocytic lymphohistiocytosis","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr."},{"issue":"3","key":"2021091015301196300_B8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","article-title":"Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/ systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation","volume":"10","author":"Castillo","year":"2009","journal-title":"Pediatr Crit Care Med."},{"issue":"8","key":"2021091015301196300_B9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"issue":"8","key":"2021091015301196300_B10","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest."},{"issue":"1","key":"2021091015301196300_B11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/blood-2017-11-814244","article-title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","volume":"132","author":"Chinn","year":"2018","journal-title":"Blood."},{"key":"2021091015301196300_B12","author":"Food and Drug Administration"},{"issue":"3","key":"2021091015301196300_B13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","article-title":"CXCR3 ligands in disease and therapy","volume":"26","author":"Van Raemdonck","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"2021091015301196300_B14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcrc.2017.02.018","article-title":"Cytokine profiles as novel diagnostic markers of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children","volume":"39","author":"Han","year":"2017","journal-title":"J Crit Care."},{"issue":"43","key":"2021091015301196300_B15","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"2021091015301196300_B16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer."},{"issue":"13","key":"2021091015301196300_B17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","volume":"131","author":"Girard-Guyonvarc\u2019h","year":"2018","journal-title":"Blood."},{"issue":"13","key":"2021091015301196300_B18","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood."},{"issue":"11","key":"2021091015301196300_B19","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood."},{"issue":"1","key":"2021091015301196300_B20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.07298.x","article-title":"Early diagnostic and prognostic significance of a specific Th1\/Th2 cytokine pattern in children with haemophagocytic syndrome","volume":"143","author":"Tang","year":"2008","journal-title":"Br J Haematol."},{"issue":"11","key":"2021091015301196300_B21","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/pbc.25058","article-title":"Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis","volume":"61","author":"Lehmberg","year":"2014","journal-title":"Pediatr Blood Cancer."},{"issue":"11","key":"2021091015301196300_B22","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1469-0691.2011.03490.x","article-title":"Evaluation of Th1\/Th2 cytokines as a rapid diagnostic tool for severe infection in paediatric haematology\/oncology patients by the use of cytometric bead array technology","volume":"17","author":"Tang","year":"2011","journal-title":"Clin Microbiol Infect."},{"issue":"6","key":"2021091015301196300_B23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jpeds.2011.11.046","article-title":"Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children","volume":"160","author":"Xu","year":"2012","journal-title":"J Pediatr."},{"issue":"1","key":"2021091015301196300_B24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-\u03b3 and interferon-\u03b3-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"2021091015301196300_B25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-\u03b3","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatology (Oxford)."},{"issue":"12","key":"2021091015301196300_B26","doi-asserted-by":"crossref","first-page":"e0226043","DOI":"10.1371\/journal.pone.0226043","article-title":"The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis","volume":"14","author":"Prencipe","year":"2019","journal-title":"PLoS One."},{"issue":"3","key":"2021091015301196300_B27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00277-013-1878-y","article-title":"IP-10\/CXCL10 and MIG\/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome","volume":"93","author":"Maruoka","year":"2014","journal-title":"Ann Hematol."},{"issue":"1","key":"2021091015301196300_B28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13052-016-0262-7","article-title":"Comparison of Th1\/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis","volume":"42","author":"Chen","year":"2016","journal-title":"Ital J Pediatr."},{"issue":"1","key":"2021091015301196300_B29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol."},{"issue":"3","key":"2021091015301196300_B30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood."},{"issue":"6","key":"2021091015301196300_B31","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest."},{"key":"2021091015301196300_B32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.trsl.2016.07.023","article-title":"Use of a mouse model to identify a blood biomarker for IFN\u03b3 activity in pediatric secondary hemophagocytic lymphohistiocytosis","volume":"180","author":"Buatois","year":"2017","journal-title":"Transl Res."},{"issue":"3","key":"2021091015301196300_B33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2249.2003.02237.x","article-title":"Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis","volume":"133","author":"Takada","year":"2003","journal-title":"Clin Exp Immunol."},{"issue":"10","key":"2021091015301196300_B34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ni.f.215","article-title":"Shouts, whispers and the kiss of death: directional secretion in T cells","volume":"9","author":"Huse","year":"2008","journal-title":"Nat Immunol."},{"issue":"1","key":"2021091015301196300_B35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1302282","article-title":"Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis","volume":"192","author":"Johnson","year":"2014","journal-title":"J Immunol."},{"issue":"1","key":"2021091015301196300_B36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer."},{"issue":"15","key":"2021091015301196300_B37","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1182\/blood-2010-08-300046","article-title":"Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis","volume":"117","author":"Sumegi","year":"2011","journal-title":"Blood."},{"issue":"7","key":"2021091015301196300_B38","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1182\/blood-2012-05-425769","article-title":"Gene-expression signatures differ between different clinical forms of familial hemophagocytic lymphohistiocytosis","volume":"121","author":"Sumegi","year":"2013","journal-title":"Blood."},{"key":"2021091015301196300_B39","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/PCC.0000000000001052","article-title":"Pathophysiology of pediatric multiple organ dysfunction syndrome","volume":"18","author":"Carcillo","year":"2017","journal-title":"Pediatr Crit Care Med."},{"issue":"3","key":"2021091015301196300_B40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","article-title":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome","volume":"37","author":"Hall","year":"2011","journal-title":"Intensive Care Med."},{"issue":"4","key":"2021091015301196300_B41","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/cc13980","article-title":"Early adaptive immune suppression in children with septic shock: a prospective observational study","volume":"18","author":"Muszynski","year":"2014","journal-title":"Crit Care."},{"issue":"12","key":"2021091015301196300_B42","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","article-title":"A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure","volume":"20","author":"Carcillo","year":"2019","journal-title":"Pediatr Crit Care Med."},{"issue":"1","key":"2021091015301196300_B43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1741-7015-7-34","article-title":"Identification of pediatric septic shock subclasses based on genome-wide expression profiling","volume":"7","author":"Wong","year":"2009","journal-title":"BMC Med."},{"issue":"4","key":"2021091015301196300_B44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/SHK.0000000000000217","article-title":"Innate immune function predicts the development of nosocomial infection in critically injured children","volume":"42","author":"Muszynski","year":"2014","journal-title":"Shock."},{"issue":"10223","key":"2021091015301196300_B45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet."},{"issue":"2","key":"2021091015301196300_B46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med."},{"issue":"26","key":"2021091015301196300_B47","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1182\/blood-2013-02-485623","article-title":"Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy [published correction appears in Blood. 2016;128(10):1441]","volume":"121","author":"Teachey","year":"2013","journal-title":"Blood."},{"issue":"6","key":"2021091015301196300_B48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discov."},{"key":"2021091015301196300_B49","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/17\/3457\/1821548\/advancesadv2021004287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/17\/3457\/1821548\/advancesadv2021004287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T01:09:48Z","timestamp":1699405788000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/17\/3457\/476721\/IFN-signature-in-the-plasma-proteome-distinguishes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":49,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021,9,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004287","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}